Whelth Research · Longevity · August 2026
The State of Longevity Clinics in America — 2026
A national analysis of longevity medicine: every U.S. city of 25,000+ reviewed, every counted practice verified against published service-evidence criteria.
Executive summary
Longevity medicine is bigger, more ordinary, and differently distributed than its image suggests. Whelth Research reviewed places in all 2,003 U.S. cities with 25,000+ residents — roughly 97,000 candidate businesses — and verified 3,577 practices offering longevity medicine under a strict, service-evidence definition. Only 634 (17.7%) are dedicated longevity clinics; the other four in five practice it as a line of business inside a medical practice (41%) or a med spa (39%). What they sell is pragmatic: the most common offering is medical weight loss (62%), followed by functional medicine (57%) and hormone therapy (56%) — while the category's marquee technology remains rare (full-body MRI: 2.2%; continuous glucose monitoring: 3%; VO₂ max: 3.4%). Geographically the field tilts hard toward the Sun Belt and Mountain West: Nevada and Arizona lead per capita, San Antonio is the single biggest city by count, and Pennsylvania stands out as the most underserved large state. The market rarely calls itself "longevity" at all — practices describing themselves with terms like functional medicine outnumbered the word longevity roughly four to one during discovery.
Where longevity medicine actually is
Each practice is counted once, at its primary location. Raw counts follow population — California, Florida, Texas — but the per-capita view tells the real story: a pronounced Sun Belt / Mountain West concentration. The pattern may reflect where retirement populations, wellness spending, and cash-pay medicine concentrate rather than where medicine itself does.
Top 15 states
| State | Verified practices | Per 100k residents |
|---|---|---|
| California | 432 | 1.10 |
| Florida | 350 | 1.49 |
| Texas | 330 | 1.04 |
| Arizona | 168 | 2.20 |
| New York | 144 | 0.72 |
| North Carolina | 126 | 1.13 |
| Colorado | 115 | 1.91 |
| Tennessee | 103 | 1.41 |
| Ohio | 97 | 0.82 |
| Illinois | 95 | 0.75 |
| Virginia | 93 | 1.05 |
| Washington | 90 | 1.12 |
| Georgia | 83 | 0.73 |
| Nevada | 75 | 2.29 |
| Missouri | 74 | 1.18 |
Most per capita
| Nevada | 2.29 |
| Arizona | 2.20 |
| Colorado | 1.91 |
| Nebraska | 1.88 |
| Kansas | 1.85 |
| Idaho | 1.77 |
| Alaska | 1.76 |
| Utah | 1.72 |
| South Dakota | 1.60 |
| Hawaii | 1.54 |
Fewest per capita
| West Virginia | 0.23 |
| Vermont | 0.31 |
| South Carolina | 0.32 |
| Pennsylvania | 0.38 |
| Delaware | 0.38 |
Top cities
| City | Verified practices |
|---|---|
| San Antonio, TX | 37 |
| New York, NY | 32 |
| Scottsdale, AZ | 32 |
| Las Vegas, NV | 31 |
| Reno, NV | 28 |
| Tucson, AZ | 27 |
| Phoenix, AZ | 25 |
| Raleigh, NC | 24 |
| Atlanta, GA | 23 |
| Fort Lauderdale, FL | 23 |
| Charlotte, NC | 22 |
| San Diego, CA | 22 |
| Denver, CO | 21 |
| Albuquerque, NM | 21 |
| Dallas, TX | 21 |
San Antonio leading New York despite having a fraction of its population is the distribution in one line: longevity medicine appears to cluster where cash-pay wellness thrives, not where medicine is most concentrated. Scottsdale, Las Vegas, Reno, and Tucson in the top six make the Sun Belt pattern unmistakable.
What longevity practices actually offer
Service data comes from each practice's own published menu — a service is counted only with a citable page from the practice's website. Percentages are shares of all 3,577 verified practices.
The center of gravity is metabolic and hormonal, not diagnostic. Medical weight loss — in practice, largely GLP-1 prescribing — is the single most common offering in American longevity medicine, ahead of even functional medicine itself. Hormone optimization in some form (HRT, TRT, thyroid) is offered by roughly two in three practices. IV therapy (49%) and peptides (31%) round out the standard toolkit.
The frontier is thin
The technologies most associated with the category's public image are its rarest offerings:
Fewer than one in twenty verified practices offers DEXA body composition; roughly one in fifty offers full-body MRI or coronary calcium scoring. The "executive physical of the future" exists — but it is a boutique layer, not the market.
What a "longevity clinic" actually is
| Practice type | Count | Share |
|---|---|---|
| Hybrid — medical practice | 1,462 | 40.9% |
| Hybrid — med spa | 1,411 | 39.4% |
| Dedicated longevity clinic | 634 | 17.7% |
| Other | 70 | 2% |
The dedicated longevity clinic — the whole practice organized around healthspan — is real but a minority: 634 nationwide. The typical provider of longevity medicine is a hybrid: a medical practice (often functional or concierge medicine) or a med spa that has added diagnostics, hormones, and metabolic care to an existing business. One consequence shows up directly in the data: 38% of verified longevity practices also offer Botox, and 32% offer dermal fillers — the aesthetic and longevity markets are converging on the same storefronts.
Five findings worth quoting
- America has 3,577 verified longevity practices — but only 634 dedicated longevity clinics. Four in five practices offering longevity medicine do it as a service line, not an identity.
- Weight loss is the front door. Medical weight loss is the #1 service in longevity medicine (62% of practices) — suggesting it was the GLP-1 era, not the biohacking era, that scaled the category.
- The longevity "tech stack" is a boutique layer. Full-body MRI (2.2%), CGM (3.0%), VO₂ max (3.4%), and multi-cancer blood screening (4.2%) are each offered by a small fraction of the market that talks about them.
- Nevada leads America in longevity clinics per capita (2.29 per 100k), followed by Arizona (2.20) and Colorado (1.91). Pennsylvania is the most underserved big state at 0.38 — a sixth of Nevada's density.
- The market doesn't call itself "longevity." In discovery, practices describing themselves with terms like functional medicine and concierge medicine outnumbered the word longevity about four to one.
Methodology
Discovery. In August 2026, Whelth Research ran a structured review of places in all 2,003 U.S. cities with populations of 25,000 or more, using five search vocabularies (longevity, functional medicine, concierge medicine, executive health, and adjacent terms) — approximately 97,000 unique places. The 6,472 strongest-signal candidates in the 200 largest metros were individually reviewed against each practice's own website. 2,382 matched practices already in Whelth's directory; 2,208 were rejected as not meeting the definition; 1,585 were newly verified; 297 could not be evaluated (sites unreachable to automated review) and are excluded from all counts.
Inclusion criteria (published verbatim). A practice is counted as offering longevity medicine when its own website evidences (a) at least one hard diagnostic service — biomarker panel, blood testing, CGM, DEXA, full-body MRI, genetic testing, sleep study, VO₂ max, coronary calcium score, multi-cancer blood screening, or functional-medicine testing — and (b) services in at least two distinct longevity categories (advanced diagnostics, regenerative therapies, hormone optimization, metabolic health, health screening, longevity practice, or performance medicine). Practices whose entire model is longevity/preventive medicine are classified as dedicated longevity clinics. Every counted service carries a citation to the practice's own page, captured verbatim at review time.
Limitations. Counts are point-in-time (August 2026). A practice without a website cannot be verified and is not counted, which undercounts the smallest operators. Service percentages reflect what practices publish, which under-reports quietly-offered services. Approximately 91,000 lower-signal places from discovery were not individually reviewed; the verified total is therefore a floor, not a ceiling. Population denominators are U.S. Census Bureau Vintage 2025 estimates (NST-EST2025).
Whelth Research, "The State of Longevity Clinics in America — 2026," August 2026. whelth.com/research/state-of-longevity-clinics-2026